Anagrelide‐induced pericardial effusion in a patient with essential thrombocythemia
Abstract Pericardial effusion leading to cardiac tamponade can occur due to a multitude of etiologies, one of which is medication adverse effects. In patients with comorbid conditions, this can prove to be a challenge in its co‐management along with the primary disease. We present a rare case of ana...
Main Authors: | David Song, Jawad Shabani, Vikash Jaiswal, Kusum Paudel, Arjun Gupta, David Rubinstein |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-04-01
|
Series: | Clinical Case Reports |
Subjects: | |
Online Access: | https://doi.org/10.1002/ccr3.7246 |
Similar Items
-
Cecal cancer with essential thrombocythemia treated by laparoscopic ileocecal resection: a case report
by: Masaya Hiyoshi, et al.
Published: (2019-06-01) -
A multicenter, open-label study for efficacy and safety evaluation of anagrelide in patients with treatment-naïve, high-risk essential thrombocythemia as a primary treatment
by: Ja Min Byun, et al.
Published: (2022-11-01) -
The role of anagrelide in the treatment of essential thrombocytaemia
by: Giuseppe Civardi, et al.
Published: (2013-05-01) -
Leg Ulcers Associated with Anagrelide
by: Tuba Oskay, et al.
Published: (2021-12-01) -
A case of acute myocardial infarction in a patient with essential thrombocythaemia treated with anagrelide
by: Ekrem Yetiskul, et al.
Published: (2024-02-01)